Diagnostics Market Research Reports & Industry Analysis
The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.
New Diagnostics Industry Reports Produced by Industry Experts
To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.
What Are the Benefits of Using MarketResearch.com?
- At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
- We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
- Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
- With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
Diagnostics Industry Research & Market Reports
-
Cell Sorting
... CAGR of 9.2% over the analysis period 2024-2030. Cell Sorters, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$862.0 Million by the end of the analysis ... Read More
-
Cell Viability Assays
... at a CAGR of 7.1% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Diagnostic Radiopharmaceuticals and Contrast Media
... Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2024-2030. Contrast Media, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$7.5 Billion ... Read More
-
Photomedicine Technologies
... CAGR of 5.9% over the analysis period 2024-2030. Lasers, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$378.5 Million by the end of the analysis period. ... Read More
-
Proton Therapy
... CAGR of 13.5% over the analysis period 2024-2030. Accelerators, one of the segments analyzed in the report, is expected to record a 13.7% CAGR and reach US$843.6 Million by the end of the analysis period. ... Read More
-
Radioimmunoassays
... 3.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$458.7 Million by the end of the analysis period. ... Read More
-
Sepsis Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Microbiology, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$749.8 Million by the end of the analysis period. ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$4.6 ... Read More
-
Laboratory Automation Workcells
... at a CAGR of 5.6% over the analysis period 2024-2030. Hardware & Software, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$2.5 Billion by the end ... Read More
-
Fertility Testing
... CAGR of 6.3% over the analysis period 2024-2030. Ovulation Predictor Kits, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$571.1 Million by the end of the ... Read More
-
Helicobacter Pylori Diagnostics
... at a CAGR of 4.8% over the analysis period 2024-2030. Invasive Test, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$556.8 Million by the end of ... Read More
-
Hybrid Operating Rooms
... at a CAGR of 12.2% over the analysis period 2024-2030. Intraoperative Diagnostic Imaging Systems, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Industrial X-ray Films
... at a CAGR of 5.4% over the analysis period 2024-2030. Oil & Gas End-Use, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$35.3 Million by the ... Read More
-
Intraoperative Imaging
... CAGR of 4.4% over the analysis period 2024-2030. Mobile C-Arms, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
-
Life Science Instrumentation
... at a CAGR of 4.6% over the analysis period 2024-2030. Spectroscopy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$24.4 Billion by the end of the ... Read More
-
X-Ray Photoelectron Spectroscopy
... at a CAGR of 4.8% over the analysis period 2024-2030. Healthcare, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$339.2 Million by the end of the ... Read More
-
Exocrine Pancreatic Insufficiency
... at a CAGR of 5.8% over the analysis period 2024-2030. Therapeutics, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.8 Billion by the end of the ... Read More
-
Veterinary CT Scanners
... at a CAGR of 5.3% over the analysis period 2024-2030. Stationary Multi Slice, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$175.7 Million by the end ... Read More
-
Women`s Health Diagnostics
... at a CAGR of 5.8% over the analysis period 2024-2030. Breast Cancer Testing, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$11.3 Billion by the end ... Read More
-
MRI Compatible Pacemaker
... at a CAGR of 4.0% over the analysis period 2024-2030. Arrhythmias, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Hemostasis Products
... CAGR of 3.7% over the analysis period 2024-2030. Infusible Hemostasis, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$8.6 Billion by the end of the analysis ... Read More
-
Zika Virus Testing
... at a CAGR of 5.8% over the analysis period 2024-2030. Molecular Testing, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$192.4 Million by the end of ... Read More
-
Acute Ischemic Stroke Diagnosis and Treatment
... reach US$3.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More
-
Vendor Neutral Archive (VNA) and PACS
... reach US$6.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. PACS, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.4 ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
Research Assistance
